DailyStocks Stock Article Search

https://www.zacks.com/commentary/2219543/top-research-reports-for-abbott-t-mobile-booking?cid=CS-ZC-FT-research_daily-2219543 Feb 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG). 0

https://www.fool.com/earnings/call-transcripts/2024/01/24/abbott-laboratories-abt-q4-2023-earnings-call-tran/?source=iedfolrf0000001 Jan 24, 2024 - ABT earnings call for the period ending December 31, 2023. 0

https://www.zacks.com/stock/news/2215065/q4-earnings-roundup-abt-gd-kmb-more?cid=CS-ZC-FT-ahead_of_wall_street-2215065 Jan 24, 2024 - A spot-check of early morning Q4 reports show some earnings misses and revenue beats; Tesla and others report after the close. 0

https://www.zacks.com/stock/news/2213563/what-s-in-store-for-zimmer-biomet-zbh-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213563 Jan 22, 2024 - Zimmer Biomet (ZBH) is expected to have gained from the uptake of Persona OsseoTi Keel Tibia for Cementless Knee Replacement in the fourth quarter. 0

https://www.zacks.com/stock/news/2213031/seeking-clues-to-abbott-abt-q4-earnings-a-peek-into-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2213031 Jan 19, 2024 - Beyond analysts' top -and-bottom-line estimates for Abbott (ABT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023. 0

https://www.zacks.com/stock/news/2212321/will-abbott-abt-beat-estimates-again-in-its-next-earnings-report?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2212321 Jan 18, 2024 - Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. 0

https://www.zacks.com/stock/news/2211543/abbott-s-abt-innovations-aid-macroeconomic-issues-stay?cid=CS-ZC-FT-analyst_blog|zer_report_update-2211543 Jan 17, 2024 - Abbott (ABT) is successfully continuing the rollout of Alinity, the company's fully integrated and automated molecular diagnostics analyzer. 0

https://www.zacks.com/commentary/2210113/top-analyst-reports-for-amd-abbott-laboratories-qualcomm?cid=CS-ZC-FT-research_daily-2210113 Jan 15, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), Abbott Laboratories (ABT) and QUALCOMM Incorporated (QCOM). 0

https://www.zacks.com/stock/news/2209765/abbott-abt-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2209765 Jan 12, 2024 - The latest trading day saw Abbott (ABT) settling at $113.92, representing a +0.37% change from its previous close. 0

https://www.zacks.com/stock/news/2207832/abbott-abt-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2207832 Jan 09, 2024 - Abbott (ABT) closed at $112.73 in the latest trading session, marking a +0.29% move from the prior day. 0